Blood tests to predict risk from abnormal heart rhythms
Part of Heart & circulation clinical trials.
This study looks at how certain substances in your blood (called biomarkers) might help predict the risk of serious heart rhythm problems. By joining, you could help doctors better understand who needs treatment to prevent dangerous heart rhythms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a ventricular arrhythmia (an irregular heartbeat from the lower chambers, like premature beats, fast rhythms, or a life-threatening rhythm).
- You are between 18 and 80 years old.
- You do not have an autoimmune disease (like lupus) or a weakened immune system, and you have not used immune-suppressing medications in the last 3 months.
- You do not have a bleeding disorder or low platelet count.
- You have not had an organ transplant and are not planning to receive one.
- You are willing to sign a consent form and cooperate with the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how heart rhythm problems affect heart function. It may help doctors better understand and treat these conditions.
This study tests a computer program that learns to spot irregular heart rhythms (arrhythmias) from standard heart tests. If it works, it could help doctors find and treat these problems faster and more accurately.
This study looks at people who have frequent abnormal signals from the upper heart (supraventricular extra beats or short runs) and how that relates to atrial fibrillation risk. If you qualify, you may help researchers understand better ways to prevent or manage certain heart rhythm problems.
This study checks a more detailed kind of heart recording (ECG) using many small sensors to better measure electrical rhythm problems. It may help doctors refine how they assess risk in people with serious or suspected dangerous heart rhythm issues.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study uses a genetic test to identify who might develop atrial fibrillation (an irregular heartbeat) in the future. Researchers believe certain genetic patterns combined with health factors can help predict this condition early, which could lead to better prevention.
Hear when a new Ventricular Arrythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.